Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

None of that is actionable.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Scooter McCabe Member Profile
 
Followed By 33
Posts 1,241
Boards Moderated 0
Alias Born 04/13/18
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/28/2020 6:07:10 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/15/2020 5:06:59 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 9/14/2020 4:31:44 PM
SA Breaking News: ALYI - Alternet Systems revenue surging with new potential customers InvestorsHub NewsWire - 9/14/2020 10:10:04 AM
Traders News Source Identifies Tomorrows NASDAQ's InvestorsHub NewsWire - 9/3/2020 8:45:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/1/2020 5:34:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2020 2:57:56 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 9/1/2020 1:47:41 PM
MICROCAP DAILY - The Exciting Story of Puration Inc (OTCMKTS: PURA) InvestorsHub NewsWire - 8/26/2020 9:02:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 4:31:34 PM
Annual Report (10-k) Edgar (US Regulatory) - 8/14/2020 5:19:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2020 5:21:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 4:34:37 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 5:07:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 4:31:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:19:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2020 7:24:49 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 6/8/2020 5:28:53 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/8/2020 6:02:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2020 5:01:56 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/2/2020 8:01:17 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 5/15/2020 8:47:08 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/12/2020 6:00:59 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/30/2020 5:28:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 5:29:47 PM
Scooter McCabe   Wednesday, 07/01/20 08:49:29 PM
Re: justdafactss post# 89870
Post # of 119524 
None of that is actionable.

1. Uplist

Nader has stated they are applying to the NYSE under exception 4a. They have to meet with the exchange and discuss why that applies to them. Getting on an exchange takes months.

Nothing actionable in saying the company has decided to try and uplist.

2. 50 million in financing.

Nader has stated they are seeking financing and shopping lenders. They have a few discussions on the table. If not there is the 100 million shares to ready to fund the company.

Nothing actionable about stating the company is seeking financing, that it is involved in discussions and it's intentions moving foward.

3. 2 billion in revenue in 2020.

During Nader's conference call he stated based on the number of vials they believe can be produced, the need of the market, that they projected 2 billion in potential revenue.

Nothing actionable in a CEO making statements that upon approval the company projects a potential revenue from it's new drug and the demand from the market. Otherwise the NYSE, NASDAQ and other exchanges would grind to a complete halt as projecting earnings suddenly becomes a crime.

4. Looks kind of haggard.

Fresh pressed suit, well tied Windsor knot, brilliant white shirt. Appears well groomed. No bags under the eyes, no discoloration from lack of sleep, no ruddy complexion from alcohol abuse. Shoulders are squared and good posture.

I would say using the word haggard is inappropriate and an incorrect analysis of his appearance.

MYTHS BUSTED

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences